European Society of Clinical Microbiology and Infectious Diseases (ESCMID): treatment guidance document for Clostridium difficile infection (CDI)

被引：291

作者：

Bauer, M. P. ^{[2
]}

Kuijper, E. J. ^{[1
]}

van Dissel, J. T. ^{[2
]}

机构：

[1] Leiden Univ, Med Ctr, Ctr Infect Dis, Dept Med Microbiol, NL-2300 RC Leiden, Netherlands

[2] Leiden Univ, Med Ctr, Ctr Infect Dis, Dept Infect Dis, NL-2300 RC Leiden, Netherlands

来源：

CLINICAL MICROBIOLOGY AND INFECTION | 2009年 / 15卷 / 12期

关键词：

Clostridium difficile; guidelines; treatment; RANDOMIZED CONTROLLED-TRIAL; DOUBLE-BLIND; INTRAVENOUS IMMUNOGLOBULIN; PSEUDOMEMBRANOUS COLITIS; ORAL VANCOMYCIN; SACCHAROMYCES-CEREVISIAE; ANTIBODY-RESPONSE; FUSIDIC ACID; RISK-FACTORS; TOXIN-A;

D O I：

10.1111/j.1469-0691.2009.03099.x

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

Clostridium difficile infection (CDI) is a potentially fatal illness with an increasing incidence worldwide. Despite extensive ongoing research into CDI treatment, management of CDI still poses important problems, such as a high propensity to relapse and refractoriness to treatment, especially when there is an ileus and oral drugs cannot be adminstered. This guideline evaluates the available literature, discusses criteria for disease severity and provides recommendations for CDI treatment, indicating level of evidence and strength of recommendation.

引用

页码：1067 / 1079

页数：13

共 81 条

[1] Recurrent Clostridium difficile colitis:: Case series involving 18 patients treated with donor stool administered via a nasogastric tube [J].

Aas, J ;

Gessert, CE ;

Bakken, JS .

CLINICAL INFECTIOUS DISEASES, 2003, 36 (05) :580-585

[2] Comparison of clinical and microbiological response to treatment of Clostridium difficile associated disease with metronidazole and vancomycin [J].

Al-Nassir, Wafa N. ;

Sethi, Ajay K. ;

Nerandzic, Michelle M. ;

Bobulsky, Greg S. ;

Jump, Robin L. P. ;

Donskey, Curtis J. .

CLINICAL INFECTIOUS DISEASES, 2008, 47 (01) :56-62

[3] Emergence of reduced susceptibility to metronidazole in Clostridium difficile [J].

Baines, Simon D. ;

O'Connor, Rachael ;

Freeman, Jane ;

Fawley, Warren N. ;

Harmanus, Celine ;

Mastrantonio, Paola ;

Kuijper, Ed J. ;

Wilcox, Mark H. .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 62 (05) :1046-1052

[4]

BAKKEN S, 2007, 45 ANN M INF DIS SOC

[5]

BARTLETT JG, 1980, GASTROENTEROLOGY, V78, P431

[6]

BARTLETT JG, 1984, REV INFECT DIS, V6, pS235

[7] Fungemia with Saccharomyces cerevisiae after treatment with Saccharomyces boulardii [J].

Bassetti, S ;

Frei, R ;

Zimmerli, W .

AMERICAN JOURNAL OF MEDICINE, 1998, 105 (01) :71-72

[8] Intravenous immunoglobulin for recurrent Clostridium difficile diarrhoea [J].

Beales, ILP .

GUT, 2002, 51 (03) :456-456

[9] Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial [J].

Besselink, Marc G. H. ;

van Santvoort, Hjalmar C. ;

Buskens, Erik ;

Boermeester, Marja A. ;

van Goor, Harry ;

Timmerman, Harro M. ;

Nieuwenhuijs, Vincent B. ;

Bollen, Thomas L. ;

van Ramshorst, Bert ;

Witteman, Ben J. M. ;

Rosman, Camiel ;

Ploeg, Rutger J. ;

Brink, Menno A. ;

Schaapherder, Alexander F. M. ;

Dejong, Cornelis H. C. ;

Wahab, Peter J. ;

van Laarhoven, Cees J. H. M. ;

van der Harst, Erwin ;

van Eijck, Casper H. J. ;

Cuesta, Miguel A. ;

Akkermans, Louis M. A. ;

Gooszen, Hein G. .

LANCET, 2008, 371 (9613) :651-659

[10] TREATMENT OF RECURRENT CLOSTRIDIUM-DIFFICILE COLITIS WITH LACTOBACILLUS GG [J].

BILLER, JA ;

KATZ, AJ ;

FLORES, AF ;

BUIE, TM ;

GORBACH, SL .

JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 1995, 21 (02) :224-226

← 1 2 3 4 5 6 7 8 9 →